Losartan Cost in Louisiana 2026: Cash Price, Medicaid, Insurance, and Savings Options

At a glance
- Cash price (generic, Louisiana retail 2026) / ~$10/month
- Brand-name Cozaar list price / ~$80/month
- Louisiana Medicaid formulary status / Not covered (standard formulary)
- Compounded losartan via 503A pharmacy / Legal in Louisiana
- Telehealth prescribing / Legal statewide
- Typical starting dose / 50 mg once daily orally
- FDA approval year / 1995
- Key indication / Hypertension, diabetic nephropathy, heart-failure risk reduction
- Discount program availability / GoodRx, NeedyMeds, manufacturer savings card
- 340B program access / Available at qualifying Louisiana federally qualified health centers
What Losartan Is and Why Louisiana Patients Use It
Losartan is an angiotensin II receptor blocker (ARB) that the FDA approved in 1995 under the brand name Cozaar [1]. It blocks the AT1 receptor, which reduces vasoconstriction and lowers aldosterone secretion, producing meaningful blood-pressure reduction in most adults within two to six weeks of reaching an effective dose [1]. Clinicians prescribe it for hypertension, to slow progression of diabetic nephropathy in type 2 diabetes with proteinuria, and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy [2].
The LIFE trial (N=9,193, Lancet 2002) demonstrated that losartan 50 to 100 mg daily reduced the composite of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol (RR 0.87 to 95% CI 0.77 to 0.98, P<0.021) over a mean follow-up of 4.8 years [2]. Stroke reduction was even larger at 25% (P<0.001) [2]. Those numbers established losartan's position on nearly every hypertension guideline in the United States, including the 2017 ACC/AHA Hypertension Guideline, which lists ARBs as first-line therapy in patients with CKD, heart failure, or diabetes [3].
Louisiana has the fourth-highest age-adjusted hypertension prevalence in the country at approximately 38% of adults, according to CDC data [4]. That makes losartan one of the most dispensed drugs in the state, which directly shapes how pharmacies price it and how aggressively discount programs compete for the business [4].
Standard dosing begins at 50 mg once daily and may be titrated to 100 mg once daily for blood-pressure control, or maintained at 50 mg daily for diabetic nephropathy per the FDA label [1]. Losartan is taken as an oral tablet and does not require special storage or refrigeration, which simplifies both retail and mail-order dispensing [1].
Losartan Cash Price in Louisiana in 2026
Generic losartan costs approximately $10 per month at Louisiana retail pharmacies when paid in cash or with a free discount coupon in 2026. That figure covers a 30-tablet supply of 50 mg tablets at chains including Walmart, Walgreens, CVS, and Winn-Dixie pharmacies operating across the state.
The price gap between brand and generic is wide. Merck's brand Cozaar carries a list price near $80 per month, but essentially no cash-paying patient needs to pay that figure because the generic has been available since 2010 [1]. The JNC-8 guideline panel noted that generic ARBs provide equivalent blood-pressure lowering to brand versions at a fraction of the cost, citing substitution as a standard of care for most patients [5].
A 90-day supply at a big-box retailer such as Walmart's $4/$10 list typically runs $10 for three months, bringing the effective monthly cost to roughly $3.33 [6]. Sam's Club and Costco pharmacies in Baton Rouge, New Orleans, and Shreveport post similar 90-day prices. Patients who do not want to drive to a membership store can use GoodRx coupons at independent pharmacies in smaller Louisiana parishes and typically pay between $8 and $14 per month depending on the specific pharmacy's negotiated rate [6].
Mail-order programs through major pharmacy benefit managers (PBMs) such as Express Scripts and CVS Caremark offer 90-day fills for roughly $10 to $15 total when a commercial plan applies a generic tier copay, or for $10 to $20 out-of-pocket without insurance at their mail-order cash desks [7].
Louisiana Medicaid Coverage for Losartan
Louisiana Medicaid does not currently list generic losartan on its standard Preferred Drug List (PDL), which means the drug is not covered without a prior authorization (PA) for standard Medicaid managed-care enrollees. That is an unusual position for a first-line antihypertensive, and it affects roughly 1.8 million Louisianans enrolled in Medicaid [8].
Patients enrolled in Louisiana Medicaid have several practical options. First, some managed-care organizations (MCOs) contracted with Louisiana Medicaid, including Aetna Better Health of Louisiana, Humana Healthy Horizons, and Healthy Blue Louisiana, may list losartan on their own supplemental formularies even when the state PDL does not [8]. Checking the specific MCO's drug list directly is the correct first step. Second, a prescribing physician can submit a prior authorization request citing clinical necessity, a documented ACE-inhibitor intolerance (typically cough), or a diabetic nephropathy indication where losartan has a specific FDA-labeled benefit [1]. Third, 340B-eligible facilities including federally qualified health centers (FQHCs), Ryan White clinics, and several Louisiana Safety Net Hospitals can dispense losartan at deeply discounted 340B prices to qualifying patients regardless of formulary status [9].
The Health Resources and Services Administration (HRSA) maintains a public database of Louisiana 340B covered entities [9]. Ochsner Health, LSU Health, and Tulane Medical Center operate 340B programs that serve uninsured and underinsured patients in the New Orleans metro area. Patients in rural parishes may access FQHCs affiliated with the Louisiana Primary Care Association [9].
The 2023 USPSTF recommendation on hypertension screening in adults reinforces that any barrier to antihypertensive access increases downstream cardiovascular risk [10]. For Louisiana Medicaid patients who cannot get coverage approved, the $10 monthly cash price at Walmart or a GoodRx-facilitated fill is affordable and eliminates wait time for PA approvals.
Commercial Insurance and Losartan Formulary Tiers in Louisiana
Most commercial insurance plans sold on Louisiana's ACA marketplace and through large employers place generic losartan on Tier 1 (preferred generic), which typically means a copay between $0 and $15 per 30-day fill depending on the plan design.
Blue Cross and Blue Shield of Louisiana, the state's dominant commercial insurer, lists losartan potassium 25 mg, 50 mg, and 100 mg tablets as Tier 1 generics on its standard formulary [11]. Humana, Aetna, and UnitedHealthcare Medicare Advantage plans operating in Louisiana also place losartan on their lowest cost-sharing tier for Medicare Part D [7]. For Medicare Part D beneficiaries in 2026, generic Tier 1 copays under most stand-alone PDPs in Louisiana run $0 to $5 per month [7].
Patients who receive losartan as a brand-name Cozaar prescription will face Tier 3 or Tier 4 non-preferred brand cost-sharing, typically $40 to $80 per 30-day fill even with insurance. A simple generic substitution request to the prescriber or pharmacist eliminates that cost entirely because generic losartan is therapeutically equivalent per the FDA Orange Book [1].
Employer-sponsored self-funded plans are not required to follow state formulary mandates, but most national PBMs automatically apply generic substitution rules that bring losartan to Tier 1 for covered employees regardless of which Louisiana employer sponsors the plan.
Compounded Losartan in Louisiana: Legal Status and Cost
Compounded losartan is legal in Louisiana when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Louisiana follows federal 503A guidelines established under the Drug Quality and Security Act, and the Louisiana Board of Pharmacy oversees all compounding activity in the state [12].
503A pharmacies compound losartan most commonly for patients who need doses not commercially available (such as 12.5 mg for pediatric patients or elderly patients with renal impairment), patients with documented allergies to tablet excipients, or patients who require a liquid formulation due to dysphagia [12]. Cost for compounded losartan through a 503A pharmacy varies by formulation and volume but can run near $0 per month for patients enrolled in specific clinical programs or charity-care arrangements, though a typical compounding fee for a custom formulation runs $20 to $50 per month at Louisiana compounding pharmacies absent those programs.
The FDA does not approve compounded drug products individually; they are exempt from the standard new drug approval process but must comply with USP Chapter 795 quality standards for non-sterile preparations [12]. Louisiana pharmacists compounds losartan using losartan potassium API and are not permitted to compound a copy of a commercially available product without clinical justification, per 503A restrictions [12].
503B outsourcing facilities, which may produce larger batches, are not the standard route for losartan compounding because losartan is commercially available and not on the FDA 503B bulks list [13]. Patients seeking compounded losartan in Louisiana should request it from a 503A pharmacy and ensure the prescription notes the specific clinical rationale [12].
Telehealth Prescribing of Losartan in Louisiana
Telehealth prescribing of losartan is fully legal in Louisiana. The state's telehealth statute, La. R.S. 40:1223.3, permits prescribing based on a valid physician-patient relationship established via synchronous audio-video telemedicine, and losartan as a non-controlled Schedule drug requires no DEA waiver or in-person examination under federal law [14].
Louisiana's State Board of Medical Examiners confirmed in 2021 guidance that antihypertensives, including ARBs, may be prescribed via telehealth following a medically appropriate evaluation that includes a review of blood-pressure readings [14]. Readings can be self-reported from a validated home blood-pressure monitor meeting AHA criteria (validated device list at heart.org) [15] or captured at a retail pharmacy kiosk.
HealthRX clinicians licensed in Louisiana can prescribe losartan following a 20 to 30 minute video consultation that reviews blood pressure history, kidney function labs, pregnancy status, and any concurrent medications. A basic metabolic panel (potassium and creatinine) is recommended before initiating losartan given its effects on serum potassium and renal perfusion, per JNC-8 guidance [5]. Patients already on losartan seeking a refill via telehealth typically need only a brief check-in with current BP readings and recent lab values [5].
The AHA notes that telehealth-delivered hypertension management achieves similar blood-pressure reductions to in-person care in properly selected patients, citing a meta-analysis of 18 RCTs showing a mean systolic BP reduction of 3.8 mmHg with telehealth vs. usual care (P<0.001) [15].
Savings Programs and Discount Cards for Losartan in Louisiana
Several practical programs reduce losartan cost to near zero for Louisiana patients who do not have coverage or whose coverage is inadequate.
GoodRx and similar platforms. GoodRx, RxSaver, and NeedyMeds all negotiate contracted rates with Louisiana retail pharmacies. GoodRx codes typically yield $8 to $14 per month for generic losartan 50 mg at Louisiana chains [6]. The platform is free to use and does not require enrollment.
Merck Patient Assistance Program. Merck operates a patient assistance program for Cozaar through the Merck Patient Assistance Program (MPAP). Eligible patients with income at or below 200% of the federal poverty level and no insurance coverage for the drug may receive brand Cozaar at no cost [16]. Louisiana residents apply directly at merck.com/patient-assistance-program. Given that generic losartan costs $10 per month, most patients have no reason to pursue the brand-assistance route, but it exists for patients with specific allergies to generic excipients.
Manufacturer Savings Card. Merck has historically offered a Cozaar savings card for commercially insured patients that reduces brand copays. In 2026, the practical value of this card for most Louisiana patients is limited because the generic is cheaper than any brand copay even after the card's discount [16].
340B Pharmacies. As noted above, qualifying patients at FQHCs and safety-net hospitals access 340B pricing, which for a drug like generic losartan may bring the cost to $1 to $3 per month [9].
NeedyMeds. The NeedyMeds database lists state-specific pharmaceutical assistance programs. Louisiana-specific programs for cardiovascular drugs include some county-health-department partnerships that can supply losartan at no cost to uninsured residents [17].
Split-tablet strategy. For patients on 50 mg once daily, purchasing 100 mg tablets and splitting them halves the per-tablet cost at pharmacies that charge the same price regardless of tablet strength. This approach requires physician approval and a pill splitter, but the American Heart Association notes it is acceptable for scored tablets [15]. Losartan 100 mg tablets are scored and safe to split per the FDA label [1].
Losartan Dosing, Safety, and Monitoring in Louisiana Patients
Starting at 50 mg once daily is appropriate for most adult hypertensive patients. The dose may be increased to 100 mg once daily if blood-pressure control is inadequate after two to four weeks [1]. For diabetic nephropathy, the RENAAL trial (N=1,513) showed that losartan 100 mg daily reduced the composite of doubling serum creatinine, ESRD, or death by 16% versus placebo (P<0.02) over a mean of 3.4 years [18]. Clinicians should use the 100 mg dose in proteinuric diabetic nephropathy patients who tolerate it.
Losartan is contraindicated in pregnancy (FDA Pregnancy Category D/X for second and third trimesters) and in patients concurrently taking aliskiren who have diabetes or GFR <60 mL/min [1]. Black box warning language from the FDA label states: "Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. When pregnancy is detected, discontinue losartan as soon as possible" [1].
Baseline potassium and creatinine should be checked before starting; recheck at two to four weeks after initiation or dose change and then annually in stable patients [5]. Louisiana's high rates of type 2 diabetes (12.4% of adults, per CDC 2023) [4] mean many losartan patients carry additional CKD risk that warrants closer monitoring every three to six months once eGFR falls below 60 mL/min/1.73m2 [3].
Drug interactions worth flagging for Louisiana prescribers: NSAIDs (widely used for musculoskeletal pain) blunt losartan's antihypertensive effect and may accelerate renal decline in CKD patients [1]. Lithium levels rise with ARBs and require monitoring [1]. Potassium-sparing diuretics combined with losartan increase hyperkalemia risk [1].
How to Get Losartan in Louisiana for the Lowest Possible Cost
The cheapest path to losartan in Louisiana in 2026 depends on insurance status. Insured patients on a commercial or Medicare plan should confirm Tier 1 generic placement and ask the pharmacist to apply it as a generic if the prescription was written for Cozaar. Medicaid patients should contact their MCO before assuming non-coverage, then pursue 340B access or the $10 GoodRx cash price if coverage is denied. Uninsured patients should go straight to Walmart's $10/90-day generic program or use a GoodRx coupon at any Louisiana pharmacy.
Telehealth prescribing through a service licensed in Louisiana removes the need for an in-person visit, which saves additional out-of-pocket cost for patients without primary care. The visit typically costs $49 to $75 for an initial hypertension consultation at most telehealth platforms, versus a $150 to $250 primary care office visit without insurance [14].
The ACC/AHA 2017 guideline notes that "cost is one of the most modifiable barriers to antihypertensive medication adherence" and recommends that clinicians proactively discuss generic options and assistance programs at each prescription encounter [3]. Generic losartan at $10 per month satisfies that recommendation for most Louisiana patients.
Frequently asked questions
›How much does losartan cost in Louisiana?
›Does Louisiana Medicaid cover losartan?
›Is compounded losartan legal in Louisiana?
›Can I get losartan via telehealth in Louisiana?
›Which insurance plans cover losartan in Louisiana?
›What's the cheapest way to get losartan in Louisiana?
›Are there Louisiana losartan discount programs?
›How does the Merck savings card work in Louisiana?
References
- FDA. Cozaar (losartan potassium) Prescribing Information. NDA 020203. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020203
- Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Centers for Disease Control and Prevention. Hypertension Prevalence by State. CDC BRFSS. https://www.cdc.gov/bloodpressure/data/index.htm
- James PA, Oparil S, Carter BL, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520. https://pubmed.ncbi.nlm.nih.gov/24352797/
- Desai NR, Choudhry NK. Impediments to adherence to post myocardial infarction medications. Curr Cardiol Rep. 2013;15(1):322. https://pubmed.ncbi.nlm.nih.gov/23250661/
- Medicare Part D Drug Spending Dashboard. Centers for Medicare and Medicaid Services. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Information-on-Prescription-Drugs/MedicarePartD
- Medicaid and CHIP Program (MACStats). Centers for Medicare and Medicaid Services. https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html
- Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa/index.html
- US Preventive Services Task Force. Hypertension in Adults: Screening. April 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-in-adults-screening
- Eapen ZJ, Liang L, Fonarow GC, et al. Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients. JACC Heart Fail. 2013;1(3):245-251. https://pubmed.ncbi.nlm.nih.gov/24621871/
- FDA. Compounding: 503A. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- FDA. 503B Outsourcing Facilities. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/outsourcing-facility-information
- Center for Connected Health Policy. Louisiana Telehealth Laws and Reimbursement Policies. https://www.cchpca.org/state/louisiana/
- Omboni S, McManus RJ, Bosworth HB, et al. Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension: An International Expert Position Paper. Hypertension. 2020;76(5):1368-1383. https://pubmed.ncbi.nlm.nih.gov/32921195/
- Merck Patient Assistance Program. Merck Prescription Assistance. https://www.merck.com/patient-assistance-program/
- NeedyMeds. Pharmaceutical Assistance Programs Database. https://www.needymeds.org/
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/